BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2019
View Archived Issues
Passage Bio announces new gene therapy clinical program for infantile Krabbe disease
Read More
Promising preclinical data presented for 4D-C102 and 4D-310
Read More
Patient enrollment ongoing in phase I study of BIIB-100
Read More
Dermavant Sciences initiates phase III study of tapinarof for the treatment of plaque psoriasis
Read More
A-Alpha Bio receives grant to develop drugs for infectious diseases
Read More
Fragile X quick-ish fix?
Read More
First phase I results for anti-GITR antibody MK-4166 in patients with advanced solid tumors
Read More
DNA repair pipeline stretches from POLO to pre-preclinical
Read More
Jiangsu Hengrui Medicine's camrelizumab receives first approval in China for treatment of lymphoma
Read More
Merck & Co. identifies new IDO-1 inhibitors
Read More
EZH2 inhibitors disclosed by Constellation Pharmaceuticals
Read More
Angex Pharmaceutical patents neurotrophic tyrosine kinase receptor inhibitors
Read More
Bristol-Myers Squibb discloses integrin alphav antagonists
Read More
Respiratory syncytial virus inhibitors patented by Enanta Pharmaceuticals
Read More
Phase III studies of Xolair in chronic rhinosinusitis with nasal polyps meet coprimary endpoints
Read More
Promising antitumor activity of olaparib against heavily pretreated mCRPC with DDR gene defects
Read More
FDA responds to Oncology Venture's IND for proposed pivotal phase III study of LiPlaCis
Read More
Kite, Humanigen evaluate investigational combination therapy for lymphoma
Read More
Phase I results provided for JNJ-61186372 in non-small cell lung cancer
Read More
Avacta plans clinical trial of TMAC linker next year
Read More
Talaris presents quality-of-life data on FCR-001
Read More
Preliminary activity seen with U3-1402 in resistant EGFR-mutant non-small cell lung cancer
Read More
Gamida Cell presents clinical and translational data from phase I/II study of omidubicel
Read More
Phase II COPD study finds no effect of CHF-6001 on lung function
Read More